Take home message: A functionally robust model of the bronchial mucosa for drug discovery and preclinical testing.
INTRODUCTION
Human airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD) are complex multi-factorial diseases; both genetic and environmental components contribute to their pathology. While limited investigations can be undertaken in humans following in vivo challenge with agents like allergens, respiratory viruses, ozone or diesel exhaust fumes, these approaches are not amenable to detailed mechanistic studies requiring interventions that cannot be used ethically in people (1) . As an alternative, small animals, such as rodents, are widely used to create disease models as an integrated physiological system for studying pathological mechanisms (2;3). These models benefit from transgenic and gene knockout approaches, allowing investigation of the precise function of specific molecules in a pathologic process (4) .
However, animal models fail to reproduce all features of human asthma or COPD, especially the complex interplay between genetic and environmental stimuli that together drive the disease (5;6). Thus, there is an urgent need to develop human cell-based models of the airway which more accurately recapitulate aspects the human airways.
Several human tissue/cell-based models have been developed, including in vivo heterotypic xenografts (7) , ex vivo tissue explants (8) , lung slices (9) or in vitro cultures of primary cells derived from airway disease patients (10) . Such models have the advantage of using cells containing relevant genetic and epigenetic information that contribute to underlying pathogenetic processes, increasing confidence in results from mechanistic studies, including target identification and validation, as well as toxicological testing. Tissue explants offer the advantage of retaining the in vivo architecture, but they are of limited life-span ex vivo and do not preserve an intact epithelial barrier which compromises studies involving challenge with environmental stimuli. As an alternative, polarised, differentiated epithelial cultures are now widely employed for in vitro epithelial response studies. These models have allowed identification of differences in epithelial function in asthma and COPD (10;11) , consistent with the epithelium playing a key role in translating gene-environment interactions in airway disease. However, even these models have limitations, as they are a single cell-type and do not recapitulate the complex cell-cell and cell-matrix interactions that occur in vivo. Such interactions are critical for control of tissue homeostasis and repair after injury (12) .
The airway epithelial-mesenchymal trophic unit (EMTU) was originally proposed by Evans and colleagues (13) to highlight the importance of airway structural cells in controlling tissue homeostasis. According to this model, the epithelium and underlying mesenchymal cells communicate in a bi-directional way to control responses to environmental stimuli. We have postulated previously that abnormal epithelial responses to environmental stimuli are propagated and amplified within the EMTU, leading to augmented inflammatory and remodeling responses in asthma and other airway diseases (12) . Evidence of cellular cross-talk has already been demonstrated in simple experiments using epithelial-derived conditioned media or epithelialfibroblast co-cultures, where fibroblasts respond to epithelial-derived signals to drive inflammatory or remodeling responses (14) . However, no studies have been performed in which an intact epithelial cell layer and fibroblasts are in intimate contact, surrounded by their own matrix. This is a severe deficiency in current models, since abnormalities in matrix organisation and mechanical properties are now recognised as contributing to disease pathogenesis (15;16) . Thus, the availability of an integrated model of human bronchial mucosa is paramount. For this reason, our aim was to develop a 3D outgrowth model of the human bronchial mucosa, starting from bronchial biopsies acquired during bronchoscopy. We postulated that outgrowth from bronchial tissue would enable the structural cells to develop a mucosal structure that recapitulated in vivo tissue architecture. Here we describe the model and its morphological, structural and ultra-structural characteristics, as well as its functional properties relevant to epithelial barrier function and extracellular matrix remodeling independent of inflammatory cells.
METHODS

Patient Characterization and Fiberoptic Bronchoscopy
Subjects without lung disease were recruited at Southampton General Hospital, Southampton, UK or the University of Palermo and La Maddalena clinic, Palermo, Italy following ethical approval from the relevant Ethics Committee and informed consent. Bronchial biopsies were obtained by fiberoptic bronchoscopy (FB-20D; Olympus, Japan) in accordance with standard published guidelines (17) and placed in ice-cold DMEM containing 20% fetal bovine serum (FBS), 50IU/ml penicillin, 50μg/ml streptomycin, 30ng/ml amphotericin B and 1mM glutamine (transportation medium). Tissue was transferred into 5cm 2 Figure   1A ). During the first week, the dose of amphotericin B in the BEGM was doubled; thereafter, the normal dose was used. The growth medium was replaced every 48 hours during the culture period.
The culture develops as an outgrowth of a coherent sheet of cells from the biopsy to form a multi-layered structure; the outgrowth was monitored using contrast phase microscopy and when the cell layer was confluent (around 30 days), the biopsy was removed to allow the well to be completely filled with a cell layer; if sufficient tissue remained, this was used to develop a new outgrowth culture. Transepithelial Electrical Resistance (TEER) was measured using chopstick electrodes (EVOM voltohmmeter, World Precision Instruments, UK). CSE was prepared as previously described (18) . After completion of differentiation (around day 28), mature cultures 
Methylene blue staining of semi thin sections
At Days 4, 8, and 12, cultures were fixed, post-fixed and dehydrated before embedding in Epon resin. Semithin (2μm) sections were then cut and placed on glass slides. The specimens were stained with methylene blue solution (Sigma-Aldrich, UK) and observed with light microscope (LEICA DM4000, Leica Microsystems, Germany).
Immunofluorescence staining
At Day 12, cultures were washed and methanol-fixed for immunostaining, as previously described (10) . The following primary Abs were used: anti-cytokeratin13 (CK13) (monoclonal IgG1 Ab, clone 1C7, Abnova, USA) and anti-alpha smooth muscle actin (aSMA) (monoclonal IgG Ab, clone 1A4, Sigma, UK). Cells were observed using a LEICA inverted fluorescent microscope.
Scanning Electron Microscopy (SEM)
At Days 10, 20 and 30, cultures were fixed in 2% paraformaldehyde and 0.5% glutaraldehyde, washed and post-fixed with 1% osmium tetroxide. Samples were washed with Millonig buffer and dehydrated in an ascending ethanol series (30, 50, 70, 95 and 100%). The samples were critical point-dried using CO 2 , attached to specimen stubs with silver tape, metallized with gold and observed using an electron microscope (JSM-6301F; JEOL Ltd, Japan).
Transmission Electron Microscopy (TEM)
At Days 10, 20 and 30, cultures were fixed, post-fixed and dehydrated before embedding in Epon resin, as previously described (19) . Ultrathin (50nm) sections were then cut and placed on Cu/Rh grids. The specimens were contrasted with 7% uranyl-acetate in methanol and Reynold's lead citrate buffer before imaging with transmission electron microscope (JEM-1220; JEOL, Japan).
RESULTS
Morphological and functional characterization of the EMTU model derived from human bronchial biopsies.
Bronchial biopsies were embedded in growth factor-reduced Matrigel ® in Transwell ® supports using BEGM/DMEM growth medium (see below) in the basolateral compartment ( Figure 1A ).
The culture developed as an outgrowth of cells from the biopsy to form a multi-layered structure.
Expansion of the cultures was monitored by contrast phase microscopy ( Figure 1B ). Time-lapse phase contrast microscopy revealed that the cultures developed as an outgrowth from the biopsy, with cells migrating as a coherent sheet (Suppl. Figure 1 ).
Initial experiments evaluated the media combinations for optimal growth of both epithelial cells and fibroblasts from the biopsy. This involved testing various ratios of BEGM (B) and DMEM/FBS (D). In 4B:1D medium, little fibroblast growth was obtained, whereas 1B:4D resulted in predominant growth of stellate fibroblasts that invaded the Matrigel ® with few epithelial cells. Use of 1B:1D supported growth of both cell types and was used for all the cultures described below. We also tested embedding the biopsies in gels cast from collagen I instead of Matrigel ® ; however the collagen gels either failed to support development of the cultures or the cultures rapidly developed necrotic centres.
Immunofluorescent staining of the outgrowth using cytokeratin 13 and alpha-smooth muscle actin antibodies showed that the leading edge of cells was epithelial with a second front of α-SMA positive cells, approximately 400-700μm from the leading edge ( Figure 2 ). The morphology of the cultures was further studied by histological staining (Figure 3 ). After 10-12 days, the nylon membrane covering the bottom of the insert was completely covered with newly grown tissue, and from that time, the culture had a three-dimensional structure. At this stage, the cells had a flattened appearance and the culture was still covered with Matrigel ® , but after 20 culture days the matrix was remodeled to spontaneously form an air-interface (ALI). This resulted in development of a multicellular layer with surface microvilli and some ciliated cells, and was accompanied by an increase in TEER which plateaued after around 7 days post-ALI (Fig 3B) . By 30 days of culture, many goblet cells and ciliated cells were evident and the morphological features of the outgrowths did not change significantly after this point. Video microscopy of the live cultures demonstrated that the cilia were functionally active (Suppl. Figure 2 ). In our experience, unless specific damage occurred during the culture period (eg.
contamination with infectious organisms), and proper culture conditions were maintained, these 3D outgrowths could be maintained for over a year.
Ultrastructural characterization of the EMTU model derived from human bronchial tissue.
Electron microscopy was used to study the ultrastructural features of the culture models. As shown in Figure 4 , the cultures showed a progressive development and differentiation of their This possibility was further explored using TEM on 30-day-old cultures, where it was possible to identify two distinct strata: the top one formed of a layer of pseudostratified epithelial cells and the bottom one formed by ECM interspersed with isolated fibroblast-like cells ( Figure 7A ). In the lower mesenchymal cell layer, there was a well-defined ECM and the fibroblasts possessed lipid droplets similar to those found in hepatic stellate cells (20) (Figure 7B ). They also exhibited cytoplasmic processes with caveolae-like structures (Supplemental Figure 3A) , extruding proteic-like material into the extracellular space to eventually form the structured ECM surrounding the cells. The fibrillar material surrounding the fibroblasts exhibited the characteristic D-banding of collagen fibrils, suggesting production of mature ECM ( Figure 7C and Supplemental Figure 3B ). In addition to epithelial cells and fibroblasts, EM did not identify other cell types, as confirmed by immunofluorescence staining: the cultures did not express CD3, CD4, CD8, CD18, CD28, CD45, CD64, CD68 or MPO (markers of leukocytes, lymphocytes, macrophages and neutrophils) (data not shown).
Response of the EMTU Model to CSE exposure
Once mature cultures had formed, their response to CSE was evaluated. Fresh medium containing 10 or 30% CSE was added to the cultures every 48 hours for 14 days, with control cells being exposed to medium alone. While the cultures tolerated repetitive challenges using 10% CSE with no loss of barrier function ( Figure 8A ), 30% CSE eventually caused disruption of the barrier after around 5-7 days of continuous CSE exposure ( Figure 8A ). Nonetheless, even after 14 days of repeated exposure to 30% CSE, the cultures retained the ability to secrete significantly (p<0.05) more IL-8 than control cultures (mean (±SD) = 8137±138 versus 5585±4 pg/ml IL-8 released between days 12 and 14 of the challenge using cultures from 2 independent donors). A concentration of 15% CSE was used to evaluate the effect of repetitive smoke challenge on the ultrastructure of the cultures after 21 days of CSE exposure. TEM showed that CSE caused a partial remodeling of the architecture of the cultures. In particular, the apical epithelial cells completely lost their cilia which were replaced by thick microvilli, entirely covered by mucus ( Figure 8B ). Moreover, collagen production by the fibroblasts increased, resulting in a marked thickening of the basement membrane and disarray of the fibroblast layer with increased ECM production ( Figure 8C and inset).
DISCUSSION
We established a novel in vitro model mimicking the EMTU of the bronchial mucosa that could be useful in the study of the pathogenesis of lung diseases such as asthma and COPD. This model offers the possibility to conduct long term experiments, evaluate interactions between different cell populations in a three-dimensional environment and administer exogenous molecules. The mature EMTU model had an ultrastructure that was similar to that observed in electron micrographs of ex vivo bronchial tissue (21), it was functionally intact as determined by TEER measurements, and able to respond to repetitive challenge with CSE. Using this novel model, we showed that chronic exposure to CSE caused morphological changes including thickening of the basement membrane, loss of cilia, increased mucus production and disarray of the lamina propria. These features of remodeling of the bronchial mucosa are typical of those observed in vivo following chronic cigarette smoke exposure (22) (23) (24) and occurred without immune cell involvement.
Primary bronchial epithelial cultures or cell lines still represent the most commonly used in vitro
human models to study airway responses to specific stimuli (25) . However, one of the main limitations of these models is the general absence of ECM components and the loss of proper cell-cell interactions that arises from the former. In recent years, the aspiration to recapitulate a 3D tissue micro-architecture has prompted the development of more innovative, integrated models using tissue engineering (25;26) or xenograft models (7). While co-culture models have been developed (27;28), they utilize bronchial epithelial cells and fibroblasts that have initially been cultured separately and co-cultured in a range of formats including Transwell ® systems (or similar synthetic polymer supports (28)), where the epithelial cells and fibroblasts are physically separated by porous supports. Probably the most 'natural' system to date involves placing epithelial cells onto the surface of collagen gels containing embedded fibroblasts (29) . However, even though collagen is a natural product, it is artificially cast and the fibroblasts are already phenotypically modified by culture on plastic. Furthermore, these models have a relatively short life, so it is not possible to undertake long-term experiments. Nonetheless, such a model has been used to investigate the effects whole smoke exposure with clear evidence of decreased cilia and increased goblet cell differentiation, but ECM remodeling was not explored (30) . The alternative xenograft approach involves seeding human airway epithelial cells into decellularized rat tracheas and culturing in the flanks of nude mice (7) . While grafts seeded with epithelial cells from asthmatic donors had three times more fibrillar collagen compared to non-asthmatic grafts, this presumably reflects migration of rodent mesenchymal cells into the graft. In the current EMTU model, both epithelial cells and fibroblasts grow out autonomously from the bronchial biopsy into a 3D gel, whose composition is similar to that of normal ECM. After the initial expansion phase and turnover of the Matrigel ® to produce an ALI, fibroblasts start to produce newly formed ECM, structurally distinct from the Matrigel 
